Bank of New York Mellon’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-89,138
| Closed | -$552K | – | 4676 |
|
|
2022
Q1 | $552K | Sell |
89,138
-5
| -0% | -$31 | ﹤0.01% | 3647 |
|
|
2021
Q4 | $1.13M | Buy |
89,143
+27,817
| +45% | +$351K | ﹤0.01% | 3317 |
|
|
2021
Q3 | $5.62M | Buy |
61,326
+5,978
| +11% | +$548K | ﹤0.01% | 2423 |
|
|
2021
Q2 | $2.93M | Sell |
55,348
-3,768
| -6% | -$200K | ﹤0.01% | 2765 |
|
|
2021
Q1 | $2.13M | Sell |
59,116
-1,622
| -3% | -$58.4K | ﹤0.01% | 2891 |
|
|
2020
Q4 | $1.69M | Sell |
60,738
-16,006
| -21% | -$445K | ﹤0.01% | 2943 |
|
|
2020
Q3 | $3.84M | Buy |
76,744
+452
| +0.6% | +$22.6K | ﹤0.01% | 2356 |
|
|
2020
Q2 | $3.53M | Buy |
76,292
+21,483
| +39% | +$995K | ﹤0.01% | 2379 |
|
|
2020
Q1 | $2.5M | Buy |
54,809
+15,942
| +41% | +$727K | ﹤0.01% | 2441 |
|
|
2019
Q4 | $2.18M | Buy |
38,867
+25,014
| +181% | +$1.4M | ﹤0.01% | 2773 |
|
|
2019
Q3 | $345K | Buy |
13,853
+5,646
| +69% | +$141K | ﹤0.01% | 3719 |
|
|
2019
Q2 | $349K | Buy |
+8,207
| New | +$349K | ﹤0.01% | 3749 |
|